Literature DB >> 27449938

Proline-rich Antimicrobial Peptides Optimized for Binding to Escherichia coli Chaperone DnaK.

Daniel Knappe1, Tina Goldbach, Marcus P D Hatfield, Nicholas Y Palermo, Stefanie Weinert, Norbert Sträter, Ralf Hoffmann, Sándor Lovas2.   

Abstract

The bacterial protein DnaK promotes folding of newly synthesized polypeptide chains, refolding of misfolded proteins, and protein trafficking. Assisted refolding is especially important under stress conditions induced by antibiotic therapies reducing the desired bactericidal effects. DnaK is supposedly targeted by proline-rich antimicrobial peptides (PrAMPs), but Escherichia coli ΔdnaK mutants and wild type strains are equally susceptible indicating further intracellular targets, such as the 70S ribosome. Crystal structures of PrAMPDnaK- complexes revealed forward and reverse binding modes at the substrate binding domain. Here, we used these ligand-target structures for the first time to rationally optimize peptides using molecular modeling and docking leading to the prediction of four-residue long sequences for improved binding to DnaK. When these sequences were used to replace the original sequence stretch in Onc72, most peptides showed significantly reduced dissociation constants (Kd) determined by fluorescence polarization. In a second approach, the X-ray structures of Api88 and Onc72 bound to DnaK were examined to predict substitutions prone to stronger interactions. Among the 36 peptides obtained from both approaches, six derivatives bound to DnaK with more than 10-fold higher affinities (Kd values in the low micromolar to nanomolar range). Peptides binding stronger to DnaK showed the same minimal inhibitory concentrations against wild type E. coli as the original peptide, but were slightly less active for ΔdnaK mutants. However, one peptide was able to overcome the resistance in an E. coli mutant lacking the SbmA transporter obligatory for the uptake of PrAMPs including Api88 and Onc72. Thus, it´s tempting to speculate that DnaK might be involved in the translocation of PrAMPs into E. coli.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27449938     DOI: 10.2174/0929866523666160719124712

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  11 in total

1.  Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.

Authors:  Pin-Kuang Lai; Daniel T Tresnak; Benjamin J Hackel
Journal:  Biotechnol Bioeng       Date:  2019-07-21       Impact factor: 4.530

Review 2.  Stability of Therapeutic Enzymes: Challenges and Recent Advances.

Authors:  Shubhrima Ghosh; Shahenvaz Alam; Anurag S Rathore; S K Khare
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 3.  Screening and Optimizing Antimicrobial Peptides by Using SPOT-Synthesis.

Authors:  Paula M López-Pérez; Elizabeth Grimsey; Luc Bourne; Ralf Mikut; Kai Hilpert
Journal:  Front Chem       Date:  2017-04-12       Impact factor: 5.221

4.  In vivo Efficacy and Pharmacokinetics of Optimized Apidaecin Analogs.

Authors:  Rico Schmidt; Daniel Knappe; Elisabeth Wende; Eszter Ostorházi; Ralf Hoffmann
Journal:  Front Chem       Date:  2017-03-20       Impact factor: 5.221

5.  Synergy Pattern of Short Cationic Antimicrobial Peptides Against Multidrug-Resistant Pseudomonas aeruginosa.

Authors:  Serge Ruden; Annika Rieder; Irina Chis Ster; Thomas Schwartz; Ralf Mikut; Kai Hilpert
Journal:  Front Microbiol       Date:  2019-11-28       Impact factor: 5.640

Review 6.  Multitalented Synthetic Antimicrobial Peptides and Their Antibacterial, Antifungal and Antiviral Mechanisms.

Authors:  Tania Vanzolini; Michela Bruschi; Andrea C Rinaldi; Mauro Magnani; Alessandra Fraternale
Journal:  Int J Mol Sci       Date:  2022-01-04       Impact factor: 5.923

7.  Functional Effects of ARV-1502 Analogs Against Bacterial Hsp70 and Implications for Antimicrobial Activity.

Authors:  Alexandra Brakel; Lisa Kolano; Carl N Kraus; Laszlo Otvos; Ralf Hoffmann
Journal:  Front Chem       Date:  2022-02-09       Impact factor: 5.221

8.  Rational Designed Hybrid Peptides Show up to a 6-Fold Increase in Antimicrobial Activity and Demonstrate Different Ultrastructural Changes as the Parental Peptides Measured by BioSAXS.

Authors:  Kai Hilpert; Jurnorain Gani; Christoph Rumancev; Nathan Simpson; Paula Matilde Lopez-Perez; Vasil M Garamus; Andreas Robert von Gundlach; Petar Markov; Marco Scocchi; Ralf Mikut; Axel Rosenhahn
Journal:  Front Pharmacol       Date:  2021-12-03       Impact factor: 5.810

9.  Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum.

Authors:  Roland Böttger; Ralf Hoffmann; Daniel Knappe
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

10.  Influence of Substitutions in the Binding Motif of Proline-Rich Antimicrobial Peptide ARV-1502 on 70S Ribosome Binding and Antimicrobial Activity.

Authors:  Alexandra Brakel; Andor Krizsan; Renke Itzenga; Carl N Kraus; Laszlo Otvos; Ralf Hoffmann
Journal:  Int J Mol Sci       Date:  2022-03-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.